Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsCombined Modality TherapyHematopoietic Stem Cell TransplantationGraft vs Host DiseaseWhole-Body IrradiationBone Marrow PurgingAntineoplastic Combined Chemotherapy ProtocolsBone and BonesTransplantation ConditioningHematopoietic Stem CellsStem Cell TransplantationLeukemiaStem CellsCyclophosphamideTissue DonorsAnemia, AplasticGraft SurvivalBusulfanLymphoma, Non-HodgkinTreatment OutcomeHistocompatibility TestingHematologic NeoplasmsRecurrenceTransplantation ChimeraLeukemia, Myeloid, AcuteHistocompatibilityImmunosuppressive AgentsCytomegalovirus InfectionsTime FactorsBone Marrow DiseasesRemission InductionHematopoiesisCarmustineKidney TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaMelphalanLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesColony-Forming Units AssayHodgkin DiseaseTransplantation, IsogeneicSurvival AnalysisGraft RejectionImmunosuppressionLeukemia, MyeloidImmunocompromised HostHematologic DiseasesHepatic Veno-Occlusive DiseaseAcute DiseaseMice, Inbred C57BLOpportunistic InfectionsTransplantationBone Marrow ExaminationCyclosporineBone RemodelingEtoposideCell DifferentiationRadiation ChimeraSurvival RateFollow-Up StudiesBone Marrow NeoplasmsMultiple MyelomaPeripheral Blood Stem Cell TransplantationMyelodysplastic SyndromesLiver TransplantationT-LymphocytesLymphocyte DepletionActuarial AnalysisCytarabineDisease-Free SurvivalHLA AntigensAntigens, CD34Granulocyte Colony-Stimulating FactorSalvage TherapyMycosesFatal OutcomeLymphomaHematopoietic Stem Cell MobilizationCells, CulturedLeukocyte TransfusionFlow CytometryCytomegalovirusHeart TransplantationGraft vs Host ReactionLeukocyte CountMesenchymal Stem Cell TransplantationBone DensityAspergillosisTransplantation ImmunologyPrognosisProspective StudiesCell SeparationNeutropeniaThiotepaChimeraPolymerase Chain Reaction